8 results about "Psychosis" patented technology

The application discloses a mental health evaluation method and system based on brain area electric stimulation, relates to the technical field of medical and health information science, and creatively integrates brain area electric stimulation into mental health evaluation. The basic cognitive level and neural plasticity potential of a measured person are objectively quantified through comprehensive scores before and after brain area electric stimulation, so that corresponding suitable mental health evaluation test questions are selected based on the basic cognitive level and neural plasticity potential, and the precision, sensitivity of corresponding mental tests and the mental comfort of the measured person are significantly improved. A decay quantization model of a stimulating current from an electrode to the brain is given, the decay quantization model is used to accurately control the electric quantity, and the maximum beneficial effect is realized under the condition of guaranteeing health and safety. Historical data accumulated in the application process can be effectively used to solve medical problems, such as the influence of brain area electric stimulation on child neural development evaluation, early warning of mental illness and brain function reinforcement.

A method and system for Adaptive Diagnostics for the Efficient Prescription of Treatments (ADEPT), which efficiently diagnoses an idiopathic psychosis patient and improves treatment targeting for that patient. ADEPT can be divided into two versions that use different inputs: ADEPT for measuring clinical characteristics of a patient (ADEPT-CLIN) and ADEPT for measuring cognitive performance (ADEPT-COG). The ADEPT systems identify Biotypes by accessing the database to match the characteristics of the patient to similar patients in that database. For ADEPT-CLIN, the patient's Biotype is based on similarity to existing patients on clinical characteristics. For ADEPT-COG, the patient's Biotype is based on similarity to existing patients on clinical, behavioral, motor inhibition, and cognitive features. Biotypes are used to implement targeted treatment for an individual patient. ADEPT is continuously re-trained using new cases and novel laboratory tests to improve precision of Biotypes diagnosis and the accuracy of selecting treatments for individual patients.

A method and system for psychopathological diagnosis are proposed. The method may include capturing video of a subject, extracting a vibration image of the subject from the video, extracting, from the vibration image, the psychophysiological information, changes of energy metabolism, and a plurality of parameters related to emotional states of the subject, and performing psychopathological evaluation and diagnosis by using the changes of the psychophysiological information, the changes of the energy metabolism, and the parameters.

The utility model relates to a fixing device and a foot ring device and system for interfering escape of a psychopath. The fixing device comprises a first fixing unit, a second fixing unit, a third fixing unit, a locking unit and a movable unit. The fixing device has the advantages that the movable unit is arranged to be of a structure with different upper and lower radial sizes and is in sliding connection with the second fixing unit to change the state of the second fixing unit, so that the second fixing unit and the locking unit are locked or unlocked; the relative positions of the first fixing unit, the second fixing unit and the third fixing unit can be easily fixed, separation is not prone to occurring, and disassembly is easy and convenient.

The present invention relates to use of particular substituted heterocycle fused gamma-carbolines as described herein, in free, pharmaceutically acceptable salt or prodrug form, and pharmaceutical composition comprising the same optionally in combination with one or more agents, for the prophylaxis or treatment of one or more disorders associated with dementia, particularly behavioral or mood disturbances (e.g., agitation / aggression), psychosis, depression and sleep disturbances among others in patients suffering from dementia.

The utility model relates to a medicine spraying bracelet device, which is used for psychiatric patients and comprises a main body unit, a watchband unit, a base unit, a medicine spraying unit, at least one driving unit and a control unit. The pesticide spraying device has the advantages that the base unit is connected with the driving unit and the pesticide spraying unit and covers the driving unit and the pesticide spraying unit, the pesticide spraying unit can be driven to slide relative to the main body unit, water can be prevented, and the installation space is saved; the medicine spraying unit is in sliding connection with the main body unit, so that calming medicine can be sprayed to the hands of a patient in time to paralyze the hands temporarily, violent behaviors of the patient on others are disturbed, and the situation that the medicine enters the main body unit to damp the main body unit can be avoided; the problem that a psychopath lacks a timely intervention device when applying violence to others is solved.

The present invention recognizes that there is an unsatisfied need for the treatment of mild cognitive disorders. A first aspect of the present invention relates generally to a method of treating, alleviating or ameliorating mild cognitive impairment in a subject. A second aspect of the invention generally relates to a method of treating, alleviating or ameliorating Alzheimer's disease in a subject. A third aspect of the present invention generally relates to a method of treating, alleviating or ameliorating Alzheimer's disease psychosis in a subject. A fourth aspect of the invention generally relates to a method of treating, alleviating or ameliorating Alzheimer's disease behavior, aggressiveness, agitation, anger, astrophe, or a combination thereof in a subject. A fifth aspect of the invention generally relates to a method of treating, alleviating or ameliorating early onset Alzheimer's disease in a subject.

The present disclosure relates to indole derivatives of general Formula (I), to processes for their preparation, to compositions including indole derivatives of general Formula (I), and to their use in activation of a serotonin receptors in a cell, as well as to treating diseases, disorders, or conditions by activation of a serotonin receptors in a cell. The diseases, disorders, or conditions include, for example, psychosis, mental illnesses and CNS disorders.